BioSpace News Archive

Press Releases

aTyr Pharma to Present at Upcoming Investor Conferences scheduled to take place in May and June 2025

May 20, 2025
·
2 min read
Press Releases

ALX Oncology Highlights Differentiated Design, Preclinical Data and Development Plans for EGFR-Targeted ADC, ALX2004, in R&D Webcast Event

May 20, 2025
·
4 min read
Press Releases

Praxis Precision Medicines to Participate in Upcoming Conferences

May 20, 2025
·
2 min read
Press Releases

Efficacy Results Announced from Cingulate’s Phase 3 Pediatric Study of CTx-1301 (dexmethylphenidate) for ADHD

May 20, 2025
·
8 min read
Press Releases

Legend Biotech to Host Investor Event During the 2025 American Society of Clinical Oncology (ASCO) Annual Meeting

May 20, 2025
·
1 min read
Press Releases

NovelMed’s Phase II Data in Paroxysmal Nocturnal Hemoglobinuria (PNH) Patients: Ruxoprubart Shows Best-in-Class Efficacy as Monotherapy

May 20, 2025
·
11 min read
Press Releases

Kymera Therapeutics Presents New Preclinical Data for KT-621, a First-In-Class, Oral STAT6 Degrader at the American Thoracic Society International Conference

May 20, 2025
·
8 min read
Press Releases

Persist AI Launches Cloud Lab to Accelerate Pharmaceutical Formulation Development, Raises $12M Series A Funding

May 20, 2025
·
5 min read
Press Releases

Early and Sustained Increase in Serum TTR Levels by Acoramidis Independently Predicted Improved Survival in the ATTRibute-CM Study

May 20, 2025
·
10 min read
Press Releases

Statistically significant and clinically meaningful BATURA Phase III trial results provide new evidence for AIRSUPRA as standard of care for as-needed rescue treatment in asthma

May 20, 2025
·
14 min read